Core Life Analytics Closes €1M Series A Deal
The Netherlands-based data analytics company, Core Life Analytics, has closed a €1m Series A financing round. The investor team is composed of BOM Brabant Ventures, Utrecht Holdings and TechFund One.
Core Life Analytics markets the StratoMineR data analytics platform in the life sciences sector. StratoMineR enables biologists to analyze complex biological datasets without the need for internal data analysis support. The software is being successfully used by scientists at well established companies such as Pfizer, Janssen, and Galapagos. CEO David Egan stated, “This investment in Core Life Analytics will allow us to expand our sales & marketing efforts, and to accelerate product development. We believe that we now have an excellent team that will be able to support us, not just with funding, but also with advice and extensive business networks.” CTO Wienand Omta stated, “This investment allows Core Life Analytics to expand our development team and accelerate the software development process by working on multiple modules simultaneously“.
Moving headquarters to Den Bosch
Core Life Analytics will be moving its headquarters from Utrecht to Den Bosch in Noord-Brabant. Sjoerd van Gorp of BOM stated, “We are very impressed with the achievements of the management team and believe that Core Life Analytics adds strong data analytics expertise to our life sciences ecosystem. By enabling biologists to unlock hidden information in increasingly complex biological datasets, new innovative drugs can be developed with an improved understanding of the underlying mechanism of action. This increases the chances of success in drug development.
We are excited at the prospect of opening an office in Den Bosch,” said CTO Wienand Omta. “Working in close proximity to The Jheronimus Academy of Data Science will present many opportunities for collaboration on software and data science projects.”
Oscar Schoots, the Director of Utrecht Holdings, was impressed with Core Life Analytics’ ability to turn a tool developed at the University Medical Center Utrecht into a viable product with a growing customer base. He is happy that Utrecht Holdings could invest together with Tech Fund One and BOM to help to grow the business. He stated, "We are very glad to see that with this Series A deal Core Life Analytics is making the next step in bringing a world class data analytics solution, that originated in the UMCU, to the global market".
"Core Life Analytics fits perfectly in our fund and we are glad to provide them, together with the BOM and Utrecht Holdings, the required funding.” said Peter van Meersbergen of TechFund One. “Their innovative business model and data analytics technology gives new opportunities to life science and pharmaceutical companies to do better and faster analysis of their research data. The current global search for vaccines and therapies for Covid-19 underline how sound this proposition is.”
Source: Core Life Analytics